Tissue Regenix Group plc
TRX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£934 | £0 | -£281 | -£643 |
| Dep. & Amort. | £527 | £0 | £520 | £390 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £143 | £0 | £0 | -£351 |
| Change in WC | -£2,346 | £0 | -£3,206 | £500 |
| Other Non-Cash | £2,408 | £0 | £1,601 | £1,470 |
| Operating Cash Flow | -£202 | £0 | -£1,366 | £1,365 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£50 | £0 | -£261 | -£154 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£542 | £0 | -£22 | -£169 |
| Investing Cash Flow | -£592 | £0 | -£283 | -£323 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £512 | £0 | £3,352 | -£140 |
| Stock Issued | £0 | £0 | £82 | £59 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£514 | £0 | -£2,563 | -£483 |
| Financing Cash Flow | -£2 | £0 | £871 | -£564 |
| Forex Effect | -£6 | £0 | £8 | -£18 |
| Net Chg. in Cash | £1,413 | -£3,461 | £3,461 | £448 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £0 | £3,461 | £0 | £3,200 |
| End Cash | £1,413 | £0 | £2,738 | £3,648 |
| Free Cash Flow | -£252 | £0 | -£1,573 | £1,211 |